학술논문
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study
Document Type
Article
Author
Brooks, K.M.; Kiser, J.J.; Ziemba, L.; Ward, S.; Rani, Y.; Cressey, T.R.; Aurpibul, L.; Masheto, G.R.; Cassim, H.; Patel, F.; Deville, J.G.; Ponatshego, P.L.; Barnabas, S.L.; Rabie, H.; Mustich, I.; Coletti, A.; Heckman, B.; Krotje, C.; Lojacono, M.; Yin, D.E.; Townley, E.; Moye, J.; Majji, S.; Acosta, E.P.; Ryan, K.; Chandasana, H.; Brothers, C.H.; Buchanan, A.M.; Flynn, P.M.
Source
In: The Lancet HIV . (The Lancet HIV, August 2023, 10(8):e506-e517)
Subject
Language
English
ISSN
23523018